Carl Zeiss AG:企業の戦略的SWOT分析

◆英語タイトル:Carl Zeiss AG - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2809
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Carl Zeiss AG – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Carl Zeiss AG (Carl Zeiss), a subsidiary of Carl Zeiss Stiftung AG, is a medical technology that manufactures and commercializes optical and optoelectronic products. The company’s product portfolio encompasses lithography optics, measuring technology, photomask systems, microscopes, medical technology products including ophthalmic diagnostic and therapeutic products, eyeglass lenses, camera and cine lenses, and binoculars. It also offers planetarium software for smaller, medium and large projection equipment for use in sky theaters, star theaters, and universe theaters. It serves a wide range of sectors including semiconductor, automotive and mechanical engineering, biomedical research and medical technology. Carl Zeiss is headquartered in Oberkochen, Germany.

Carl Zeiss AG Key Recent Developments

Dec 11,2019: Tenth record-breaking year in a row for ZEISS
Sep 27,2019: Lamprecht Named Next President and CEO of Carl Zeiss AG
Sep 24,2019: Carl Zeiss AG names new CEO
Jul 15,2019: ZEISS marks milestone for its new North America High Tech Site in Dublin, California

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Carl Zeiss AG – Key Facts
Carl Zeiss AG – Key Employees
Carl Zeiss AG – Key Employee Biographies
Carl Zeiss AG – Major Products and Services
Carl Zeiss AG – History
Carl Zeiss AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Company Overview
Carl Zeiss AG – Business Description
Business Segment: Consumer Markets
Overview
Performance
Business Segment: Cooperation Partners
Performance
Business Segment: Industry Quality & Research
Overview
Performance
Business Segment: Medical Technology
Overview
Performance
Business Segment: Other
Performance
Business Segment: Semiconductor Manufacturing Technology
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: APAC
Performance
Geographical Segment: EMEA
Performance
R&D Overview
Carl Zeiss AG – Corporate Strategy
Carl Zeiss AG – SWOT Analysis
SWOT Analysis – Overview
Carl Zeiss AG – Strengths
Carl Zeiss AG – Weaknesses
Carl Zeiss AG – Opportunities
Carl Zeiss AG – Threats
Carl Zeiss AG – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Carl Zeiss AG, Medical Equipment, Deals By Year, 2014 to YTD 2020
Carl Zeiss AG, Medical Equipment, Deals By Type, 2014 to YTD 2020
Carl Zeiss AG, Recent Deals Summary
Section 4 – Company’s Recent Developments
Dec 11, 2019: Tenth record-breaking year in a row for ZEISS
Sep 24, 2019: ZEISS Opts for continuity with new CEO
Jul 15, 2019: ZEISS marks milestone for its new North America High Tech Site in Dublin, California
May 07, 2019: Half-year figures: ZEISS innovations help achieve strong growth
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Carl Zeiss AG, Key Facts
Carl Zeiss AG, Key Employees
Carl Zeiss AG, Key Employee Biographies
Carl Zeiss AG, Major Products and Services
Carl Zeiss AG, History
Carl Zeiss AG, Subsidiaries
Carl Zeiss AG, Affiliate
Carl Zeiss AG, Key Competitors
Carl Zeiss AG, Medical Equipment, Deals By Year, 2014 to YTD 2020
Carl Zeiss AG, Medical Equipment, Deals By Type, 2014 to YTD 2020
Carl Zeiss AG, Recent Deals Summary

List of Figures
Carl Zeiss AG, Medical Equipment, Deals By Year, 2014 to YTD 2020
Carl Zeiss AG, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Carl Zeiss AG:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Glow Energy Public Co Ltd:発電所・企業SWOT分析
    Glow Energy Public Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Johnson & Johnson:企業の戦略・SWOT・財務情報
    Johnson & Johnson - Strategy, SWOT and Corporate Finance Report Summary Johnson & Johnson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Obrascon Huarte Lain SA:戦略・SWOT・企業財務分析
    Obrascon Huarte Lain SA - Strategy, SWOT and Corporate Finance Report Summary Obrascon Huarte Lain SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ono Pharmaceutical Co Ltd (4528):医療機器:M&Aディール及び事業提携情報
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzh …
  • International Consolidated Airlines Group, S.A.:企業の戦略・SWOT・財務情報
    International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Progenics Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Allahabad Bank (ALBK)
    Allahabad Bank (ALBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Vilniaus Degtine AB:企業の戦略・SWOT・財務分析
    Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report Summary Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Rotala Plc:企業の戦略・SWOT・財務情報
    Rotala Plc - Strategy, SWOT and Corporate Finance Report Summary Rotala Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Relmada Therapeutics Inc (RLMDD):企業の財務・戦略的SWOT分析
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • Juno Therapeutics Inc:企業の戦略的SWOT分析
    Juno Therapeutics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Intarcia Therapeutics Inc-医療機器分野:企業M&A・提携分析
    Summary Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that discovers, develops and commercializes drug therapies to reduce effects for chronic diseases. The company’s product candidate include ITCA 650, which is in Phase III clinical trial. Its ITCA …
  • Fujikoh Company Ltd-エネルギー分野:企業M&A・提携分析
    Summary Fujikoh Company Ltd (Fujikoh Company) is a clean technology company that offers waste recycling services. The company provides biomass and environmental recycling services. It offers construction waste recycling, waste food recycling and termite dismantling and demolition services. Fujikoh C …
  • Trina Solar Co Ltd:企業の戦略的SWOT分析
    Trina Solar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Future Fund:企業の戦略的SWOT分析
    Future Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ESSA Pharma Inc (EPI):企業の財務・戦略的SWOT分析
    Summary Essa Pharma Inc (Essa Pharma) is a drug developer that offers oncology therapeutics. The company develops EPI-506, disrupts androgen receptor transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen r …
  • Longfor Properties Co., Ltd.:戦略・SWOT・企業財務分析
    Longfor Properties Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Longfor Properties Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • FMR LLC:企業の戦略的SWOT分析
    FMR LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Carmell Therapeutics Corp:企業の製品パイプライン分析2018
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio include adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for total j …
  • United Natural Foods Inc:企業の戦略・SWOT・財務分析
    United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report Summary United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆